drugset / Trial / NCT01309360

Ultrasound-guided Axillary Plexus Block - Dose Reduction of Prilocaine

NCT01309360

Phase 4 Completed 120 enrolled Helios Research Center
Non-randomizedParallel-groupSingle-blindTreatment

Summary

Clinical aim: Does reducing the dose of local anesthetic in ultrasound-guided axillary plexus anesthesia have any effect on the success rate and additional parameters of block quality? Methodology: In this prospective cohort study three groups of 40 outpatients each were administered dosages of 1% prilocaine of either 40mL, 30mL or 20mL for axillary plexus anesthesia. Met-Hb was measured prior to administration of the block and then hourly until the Met-Hb concentration fell. Parameters of block quality and any adverse effects were recorded. The level of significance was defined with α ≤ 0.05.

Timeline

Start
2009-09
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator prilocaine Small molecule 200 mg
Comparator prilocaine Small molecule 300 mg
Comparator prilocaine Small molecule 400 mg
Comparator Midazolam Small molecule 2 mg Oral
Comparator Midazolam Small molecule 3 mg Oral
Comparator Midazolam Small molecule 3.75 mg Oral
Comparator Midazolam Small molecule 7.5 mg Oral

Indications

No indication recorded.